|
Dr. Spiegelman has been a full Professor of Cell Biology at Harvard Medical School and the Dana Farber Cancer Institute since 1991. His work is focused on the molecular basis of cell differentiation and tissue development, using adipogenesis as a model system. His groundbreaking work on transcriptional control of adipocyte development and metabolism has brought international recognition. He has also made major advances in the biochemical mechanisms of metabolic diseases, especially obesity and insulin-resistant diabetes (NIDDM). Dr. Spiegelman received a B.S. with highest honors from the College of William and Mary, and a Ph.D. from Princeton University. His graduate work was immediately followed by postdoctoral research at the Massachusetts Institute of Technology. Dr. Spiegelman was elected to the National Academy of Science in 2002 and has received numerous awards and other honors. | 